Contracts › 75N95024F00002
75N95024F00002: Process Development of Telacebec for Tuberculosis
Awarded to Mriglobal by National Institutes of Health (NIH).
$1.0Mobligated
$1.1Mpotential value
29 September 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N95024F00002 |
|---|---|
| Vehicle | 75N95024D00012 |
| Awardee | Mriglobal |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 325411 Medicinal and Botanical Manufacturing |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | MO |
| Period of performance | 30 September 2024 to 29 September 2026 |
| Potential end | 29 September 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325411 contracts · All expiring contracts · USASpending record